Clinical-stage biopharmaceutical company developing small-molecule drugs for skin diseases
Clinical-stage biopharmaceutical company developing small-molecule drugs for skin diseases. Its pipeline includes treatments for hair loss, dermatitis/eczema, psoriasis, and lupus; its lead candidate TDM-105795 targets androgenetic alopecia.